Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Syneron Medical Acquires Ultrashape - Quick Facts

RELATED NEWS
Trade ELOS now with 

Aesthetic device company Syneron Medical Ltd. (ELOS: Quote) announced Friday that it has closed the acquisition of Ultrashape Ltd., a manufacturer of non-invasive technologies for fat cell destruction and body sculpting.

The integration of Ultrashape business will begin immediately and its products will now be available through Syneron's worldwide network of direct and distributor sales channels.

Louis P. Scafuri, CEO of Syneron Medical, said, "The addition of Ultrashape's unique focused ultrasound technology will provide Syneron immediate entry into the large and attractive global market for fat cell destruction and body sculpting. Ultrashape's technology provides a differentiated, physician and patient friendly, non-invasive treatment for de-bulking and body sculpting of normal to overweight patients."

Click here to receive FREE breaking news email alerts for Syneron Medical Ltd and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Colorado based doctor Dilip Joseph, who was kidnapped by the Taliban discusses his ordeal in detail in a book published by Amazon on Tuesday. Extending the rebound seen over the course of the previous session, stocks moved sharply higher during trading on Friday. The gains on the day partly offset the recent sell-off on Wall Street, although the major averages remain well off their mid-September highs. While the Ebola outbreak in the U.S. has thus far been limited to just three people, the results of a new CBS News poll suggest that news of the disease has contributed to a sharp drop in public confidence in the Centers for Disease Control and Prevention.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.